Detalhe da pesquisa
1.
Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
J Med Virol
; 93(3): 1766-1769, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32881014
2.
Clinical and genetic factors associated with increased risk of severe liver toxicity in a monocentric cohort of HIV positive patients receiving nevirapine-based antiretroviral therapy.
BMC Infect Dis
; 18(1): 556, 2018 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30419834
3.
Impressive Boosting of Anti-S1/S2 Immunoglobulin G Production in Coronavirus Disease 2019 (COVID-19)-experienced Patients After the First Shot of the BNT162b2 Messenger RNA COVID-19 Vaccine.
Clin Infect Dis
; 73(6): e1402-e1403, 2021 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33693610
4.
Darunavir does not prevent SARS-CoV-2 infection in HIV patients.
Pharmacol Res
; 157: 104826, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325127
5.
One-year durability of anti-spike IgG to SARS-CoV-2: Preliminary data from the anticrown prospective observational study one year durability of COVID-19 anti-spike IgG.
J Infect
; 83(2): 237-279, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052240
6.
Durability of INI-containing regimens after switching from PI-containing regimens: a single-centre cohort of drug-experienced HIV-infected subjects.
Drug Des Devel Ther
; 13: 2271-2282, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31371921
7.
Persistence of Long-COVID symptoms in a heterogenous prospective cohort.
J Infect
; 84(5): 722-746, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35077770
8.
Is COVID-19 severity associated with anti-spike antibody duration? Data from the ARCOVID prospective observational study.
J Infect
; 82(5): e28-e30, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33545166